Advanced Assay Technologies and Development Methods

LOS ANGELES, Jan. 13, 2011 /PRNewswire/ -- UBM Canon and IVD Technology are proud to add a new webinar to its webcast series on The Fundamentals of In Vitro Diagnostics.  This one-hour event will focus specifically on Advanced Assay Technologies and Development Methods and will offer an in-depth analysis and discussion from experts in the industry.  

(Logo:  http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

Various market reports and studies have concluded that the future for immunoassays is a mixed bag. In the clinical laboratory, mature assays will show moderate growth while emerging assays will fuel most of the growth in this IVD segment. However, all immunoassays will have to pass the test of medical research to demonstrate their contributions to improving patient outcomes. In this webinar event, attendees will learn more about how immunoassays, combined with DNA probe studies, will have an important place in post-genomic medicine.

This Webcast will feature presentations by Neal Siegel, PhD, Chief Scientific Officer, Sword Diagnostics; Scott Dylewski, PhD, Senior Scientist, Alverix Inc.; and Nick Gee, PhD, CEO/CSO, Innova Biosciences Ltd. The Webcast concludes with a live Q&A session moderated by Richard Park, Editor-in-Chief of IVD Technology magazine.  For more information on our speakers, click here.  

Rich Nass, Content Director for the Medical Device Media Group, stated, "All attendees will receive a copy of our special DX Directions report on Advanced Assay Technologies, giving this event a real value-added feature." This Webcast will take place on Wednesday, January 26 at 2:00 p.m. ET (1:00 p.m. CT, 11:00 a.m. PT).  There is a small registration fee to attend.  The event will be archived for six months on the IVD Technology website and UBM Canon Medical Device Media Group's webcast archive.  For more information or to register for the event, please click here.  

About UBM Canon

UBM Canon, the leading B-to-B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM (UBM.L) a global provider of media and information services for professional B2B communities and markets.

SOURCE UBM Canon